A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
Clinical trial NCT06018337 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06018337
- Sponsor
- DualityBio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-18
- Primary completion
- 2026-06-01
- Enrollment
- 541
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.